US FDA allows import of syphilis drug to address shortages, Health News, ET HealthWorld


Bengaluru: The U.S. Food and Drug Administration will temporarily allow the import of a syphilis drug made by France‘s Laboratoires Delbert, the company said on Wednesday.

Laboratoires Delbert said it was coordinating with the health regulator to bring extencilline into the United States to address syphilis drug shortages, according to a letter on the FDA‘s website.

In June, Pfizer had warned that it would soon run out of supply of its drug, Bicillin L-A, used to treat syphilis and other bacterial infections in children because it has had to prioritise versions made for adults due to a spike in syphilis infections in that population at the time.

Pfizer’s penicillin products have been in shortage since April, according to the FDA’s website.

According to Survey from August, nearly a third of U.S. hospital pharmacists said that they were forced to ration, delay or cancel treatments as drug shortages in the country approach an all-time high.

Delbert’s extencilline, a form of penicillin, is not approved in the United States.

Syphilis is a preventable and curable bacterial sexually transmitted infection (STI) that affected 7.1 million adults between 15 and 49 years old in 2020, according to the World Health Organisation.

  • Published On Jan 11, 2024 at 11:08 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles

Scan to download App


Leave a Reply

Your email address will not be published. Required fields are marked *